0
3
01:26
A Black Mother And Daughter Team Fight A White Trash Mother/Daughter Team At Brawlmart
0
3
0
New Forms of Doping Using IGF-1 Is Literally Changing Athletes DNA
01:00
Wedding Ceremony In Indonesia Ends Tragically When A Young Man Doing A Traditional Dance With A Dagger Accidentally Stabs Himself In The Chest
0
1
0
00:45
OUTRAGEOUS: Evil New York State Seizes Famous Instagram Pet Squirrel From Man And Euthanizes It
1
2
0
00:55
Complete Fruitcake Liberal Has A Mental Breakdown On TikTok Because Her Dad Is Voting For Trump
3
1
0
00:52
Illegal Street Takeover Ends With A Car Using Several People As A Speed Bump
1
1
0
01:26
A Black Mother And Daughter Team Fight A White Trash Mother/Daughter Team At Brawlmart
0
3
0
01:31
This Was The Moment A Shooter Opened Fire During Halloween Celebrations In Orlando, Killing 2 And Injuring 7
0
8
0
In 2008, an Olympic year, Lee Sweeney's phone was ringing nonstop.
For a busy physiologist at the University of Pennsylvania's Perelman School of Medicine, that may be expected, but the reason behind the calls wasn't exactly run-of-the-mill.
The people on the other end of the line were athletes in search of a particular kind of fix: They wanted him to dope them -- via their genes.
In the late 1990s, Sweeney made headlines because of his research on "Schwarzenegger mice," which were up to 30% stronger than their average counterparts. Sweeney had been able to isolate the gene responsible for activating a protein -- IGF-1 -- that controls muscle growth and repair.
The main focus of his experiments was on how to limit the deterioration of muscles with age, but the results also appealed to athletes in search of a performance boost.
Word got out, however, that he was not interested.
